HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Gobbi Selected Research

Seizures (Absence Seizure)

2/2005Neuropeptide Y Y5 receptors inhibit kindling acquisition in rats.
1/2002Seizure susceptibility and epileptogenesis are decreased in transgenic rats overexpressing neuropeptide Y.
1/2000Plastic changes in neuropeptide Y receptor subtypes in experimental models of limbic seizures.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Gobbi Research Topics

Disease

5Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
04/2013 - 01/2001
4Non-Hodgkin Lymphoma (Lymphosarcoma)
09/2001 - 11/2000
3B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
03/2014 - 09/2001
3Myelodysplastic Syndromes (Myelodysplastic Syndrome)
05/2012 - 01/2001
3Multiple Myeloma
09/2005 - 01/2001
3Seizures (Absence Seizure)
02/2005 - 01/2000
2Sepsis (Septicemia)
04/2009 - 06/2008
2Bone Diseases (Bone Disease)
09/2005 - 01/2001
2Leukemia
08/2002 - 12/2001
2Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
09/2001 - 02/2000
1Body Weight (Weight, Body)
12/2022
1Anaphylaxis (Anaphylactic Shock)
11/2021
1COVID-19
11/2021
1Ascites
11/2017
1Ovarian Neoplasms (Ovarian Cancer)
11/2017
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
03/2012
1Alzheimer Disease (Alzheimer's Disease)
11/2010
1Unconsciousness (Loss of Consciousness)
04/2009
1Acute Promyelocytic Leukemia
04/2009
1Mycoses (Diseases, Fungus)
04/2009
1Opportunistic Infections (Opportunistic Infection)
04/2009
1Fungemia
04/2009
1Pathologic Complete Response
09/2005
1Neutropenia
03/2005
1Disease Progression
06/2004
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
06/2004
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
11/2002
1Residual Neoplasm
11/2002
1Hematologic Neoplasms (Hematological Malignancy)
06/2002
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
06/2002
1Hemolytic Anemia
06/2002
1Hematologic Diseases (Blood Diseases)
06/2002
1Primary Myelofibrosis (Myelosclerosis)
11/2001
1Polyneuropathies (Polyneuropathy)
09/2001
1Anxiety Disorders (Anxiety Disorder)
07/2001
1Infections
03/2001
1Agranulocytosis (Granulocytopenia)
03/2001
1Sclerosis
02/2001
1B-Cell Lymphoma (Lymphoma, B Cell)
02/2001

Drug/Important Bio-Agent (IBA)

5fludarabineIBA
03/2012 - 02/2000
3Proteins (Proteins, Gene)FDA Link
11/2017 - 01/2000
2Mitoxantrone (Novantrone)FDA LinkGeneric
03/2012 - 03/2001
2Technetium Tc 99m Sestamibi (Cardiolite)FDA LinkGeneric
09/2005 - 01/2001
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
03/2005 - 03/2001
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
03/2005 - 03/2001
2Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
03/2005 - 12/2001
2Neuropeptide YIBA
02/2005 - 01/2002
2CytosineIBA
08/2002 - 01/2001
2Kainic Acid (Kainate)IBA
01/2002 - 01/2000
2Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric
01/2001 - 02/2000
1AlbuminsIBA
12/2022
1Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
11/2021
1NanovaccinesIBA
11/2021
1Glycoproteins (Glycoprotein)IBA
11/2017
1Orosomucoid (Seromucoid)IBA
11/2017
1TrabectedinIBA
11/2017
1PM 01183IBA
11/2017
1ofatumumabFDA Link
03/2014
1Bendamustine HydrochlorideFDA Link
03/2014
1Azacitidine (5 Azacytidine)FDA Link
05/2012
1Phospholipase C betaIBA
05/2012
1Phosphoinositide Phospholipase CIBA
05/2012
1ibritumomab tiuxetan (Zevalin)FDA Link
03/2012
1YttriumIBA
03/2012
1Peptides (Polypeptides)IBA
11/2010
1Valproic Acid (Depakote)FDA LinkGeneric
04/2009
1Histone Deacetylase InhibitorsIBA
04/2009
1Tretinoin (Retinoic Acid)FDA LinkGeneric
04/2009
1Alemtuzumab (Campath)FDA Link
04/2009
1liposomal amphotericin BFDA Link
04/2009
1AD 11IBA
09/2005
1ErythropoietinFDA Link
03/2005
1Interleukin-3 (Interleukin 3)IBA
03/2005
1Imatinib Mesylate (Gleevec)FDA Link
06/2004
1Daunorubicin (Cerubidine)FDA LinkGeneric
08/2002
1Inosine Triphosphate (ITP)IBA
06/2002
1Anticonvulsants (Antiepileptic Drugs)IBA
01/2002
1tyrosine receptor (receptor, tyrosine)IBA
12/2001
1Colony-Stimulating Factors (Colony Stimulating Factor)IBA
12/2001
1Thalidomide (Thalomid)FDA Link
11/2001
1CytokinesIBA
11/2001
1Rituximab (Mabthera)FDA Link
09/2001
1AntigensIBA
09/2001
1Immunoglobulin M (IgM)IBA
09/2001
1Monoclonal AntibodiesIBA
09/2001
1Ethanol (Ethyl Alcohol)IBA
07/2001
1hypericinIBA
07/2001
1sigma Receptors (sigma Receptor)IBA
07/2001
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
03/2001
1Anti-Bacterial Agents (Antibiotics)IBA
03/2001
1Indicators and Reagents (Reagents)IBA
01/2001

Therapy/Procedure

11Therapeutics
04/2013 - 01/2000
6Drug Therapy (Chemotherapy)
04/2013 - 11/2000
2Bone Marrow Transplantation (Transplantation, Bone Marrow)
06/2008 - 11/2002
2Transplantation
07/2001 - 11/2000
1Splenectomy
06/2002
1Salvage Therapy
09/2001
1Antibiotic Prophylaxis
03/2001
1Radiotherapy
02/2001
1Chemoradiotherapy
01/2001